Related Experiment Video
Updated: May 16, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a
Yasuhiro Fujisawa1, Yasuhiro Nakamura, Yasuhiro Kawachi
1Department of Dermatology, University of Tsukuba , 1-1-1 Tennodai, Tsukuba , Japan.
The Journal of Dermatological Treatment
|December 6, 2012
Summary
Taxane-based chemotherapy significantly improved outcomes for cutaneous angiosarcoma patients compared to surgery alone. This approach offered better local control and prolonged survival, reducing recurrence rates.
Area of Science:
- Oncology
- Dermatology
- Surgical Oncology
Background:
- Cutaneous angiosarcoma is a rare and aggressive soft tissue sarcoma.
- Conventional treatment often involves wide local excision, which can be disfiguring and may not prevent recurrence.
- The efficacy of taxane-based chemotherapy as a primary treatment modality remains under investigation.
Purpose of the Study:
- To evaluate the effectiveness of taxane-based chemotherapy in treating cutaneous angiosarcoma.
- To compare taxane chemotherapy with conventional surgery-based therapy in terms of local control and overall survival.
Main Methods:
- A case-control study was conducted involving 13 patients with cutaneous angiosarcoma.
- Group A (n=5) received taxane-based chemotherapy without wide local excision.
- Group B (n=8) received conventional surgery-based therapy.
Main Results:
- No local recurrence was observed in the taxane group (Group A), while 5 out of 8 patients in the surgery group (Group B) experienced local recurrence (p < 0.05).
- Median overall survival was 31 months for Group A versus 10 months for Group B (p < 0.05).
- Kaplan-Meier survival analysis indicated significantly longer overall survival in the taxane-treated group.
Conclusions:
- Taxane-based chemotherapy demonstrated superior efficacy compared to conventional surgery-based therapy for cutaneous angiosarcoma.
- Taxane regimens, when used without extensive surgery, provided effective local control and metastasis prevention, leading to improved patient survival.
